COVID-19 patients at high risk of nerve disorders

Written By :  Dr. Nandita Mohan
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-06-28 05:00 GMT   |   Update On 2022-06-28 11:27 GMT

A new study, found that those who had tested positive for COVID-19 were at an increased risk of Alzheimer's disease, Parkinson's disease, and ischaemic stroke. Out of the 9 lac individuals that tested for COVID-19 within the study, researchers found that the 43,375 people who tested positive had a 3.5 times increased risk of being diagnosed with Alzheimer's disease, 2.6 times with...

Login or Register to read the full article

A new study, found that those who had tested positive for COVID-19 were at an increased risk of Alzheimer's disease, Parkinson's disease, and ischaemic stroke.

Out of the 9 lac individuals that tested for COVID-19 within the study, researchers found that the 43,375 people who tested positive had a 3.5 times increased risk of being diagnosed with Alzheimer's disease, 2.6 times with Parkinson's disease, 2.7 times with ischaemic stroke and a 4.8 times increased with intracerebral haemorrhage (bleeding in the brain).

While neuroinflammation may contribute to an accelerated development of neurodegenerative disorders, the authors also highlighted this could also be a possible long-term sequela after COVID-19.

The frequency of other neurodegenerative illnesses such as multiple sclerosis, myasthenia gravis, Guillain-Barré syndrome and narcolepsy did not increase after COVID-19.

Hence, the researchers concluded that these findings will help to inform our understanding of the long-term effect of COVID-19 on the body and that infections can play a role in neurodegenerative diseases and stroke.

 Reference: COVID-19 positive patients at higher risk of developing neurodegenerative disorders; EMOTIVE MEETING 8th EAN Congress 24th JUNE.

Tags:    
Article Source : 8th EAN Congress

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News